Showing 2041-2050 of 2050 results for "".
- ThromboGenics Initiates Phase 2 Clinical Study Evaluating Anti-PlGF in Combination With Anti-VEGF for Treatment of DMEhttps://modernod.com/news/thrombogenics-initiates-phase-2-clinical-study-evaluating-anti-plgf-in-combination-with-anti-vegf-for-treatment-of-dme/2480200/ThromboGenics announced that it has successfully enrolled the first patient in a phase 2 active-controlled, masked, multicenter study to evaluate the efficacy and safety of THR-317 administered in combination with ranibizumab (Lucentis, Novartis), for the treatment of DME (NCT03499223). TH
- ARVO 2018: Genentech Ophthalmology Data Highlightshttps://modernod.com/news/arvo-2018-genentech-ophthalmology-data-highlights/2480204/Genentech will be presenting several studies at the Association for Research in Vision and Ophthalmology (ARVO) meeting on April 29 – May 3 in Honolulu. Data being reported at ARVO continue to show the safety and efficacy of Lucentis (ranibizumab) as a treatment for wet age-related macular degene
- Two New Drug Classes Tied to Better Survival in Type 2 Diabeteshttps://modernod.com/news/two-new-drug-classes-tied-to-better-survival-in-type-2-diabetes/2480222/Patients with type 2 diabetes who did not achieve adequate glycemic control with metformin had improved survival during follow-up if they received add-on therapy with a sodium-glucose cotransporter 2 (SGLT-2) inhibitor or a glucagon-like peptide 1 (GLP-1) agonist rather than a dipeptidyl peptidas
- Allergan Moves in as Shire Rebuffs $63 billion Takeda Bidhttps://modernod.com/news/allergan-moves-in-as-shire-rebuffs-63-billion-takeda-bid/2480225/Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan’s Takeda Pharmaceutical, although talks are continuing, while sources said Allergan was also in competing
- Alcon Adds New Gemstone Collection to Air Optix Colors Lens Portfolio and Introduces 2-Count Packshttps://modernod.com/news/alcon-adds-new-gemstone-collection-to-air-optix-colors-lens-portfolio-and-introduces-2-count-packs/2480236/Alcon has introduced its new Air Optix Colors Gemstone Collection of color contact lenses, with three new colors – Amethyst, True Sapphire, and Turquoise. Now offering a total of 12 colors, Air Optix Colors lenses appeal to a wide range of patients and offer a strong incremental revenue potential
- Swiss Advanced Vision Launches Active IOL Concept with Real-Time Autofocushttps://modernod.com/news/swiss-advanced-vision-launches-active-iol-concept-with-real-time-autofocus/2480257/Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC (Real-Time Autofocus Servo Control), an active lens with real-time autofocus and wireless connectivity. Current lenses are fixed and suffer from optical compromises, such as light distribution, resolution, and visua
- Dallas Lighthouse for the Blind to Merge With Envisionhttps://modernod.com/news/dallas-lighthouse-for-the-blind-to-merge-with-envision/2480267/Envision announced that it has acquired the Dallas Lighthouse for the Blind. Operations will continue as normal in Dallas, and the Dallas Lighthouse for the Blind name will be retained. Financial terms of the deal were not disclosed. The merger will have positive benefits both in Te
- Stephen M. Cohen, MD, FACOGhttps://modernod.com/profiles/stephen-m-cohen-md-facog/OYBnen/Stephen M. Cohen, MD is an Associate Professor of Obstetrics & Gynecology at Albany Medical Center in Albany, NY, teaching Reproductive Endocrinology and Minimally Invasive Surgery to Residents and practicing at CNY Fertility Center based in Syracuse/ Rochester/Albany, NY. Dr. Cohen performed his R…
- Diana Shechtman, OD, FAAOhttps://modernod.com/profiles/diana-shechtman-od-faao/jmQ4xR/Dr. Diana Shechtman is a board-certified optometric physician. She completed her undergraduate studies with honors at University of Florida. She was awarded her Doctor of Optometry degree with honors by Nova Southeastern University College of Optometry. In 1999, she completed a residency focused o…
- Selina McGee, OD, FAAOhttps://modernod.com/profiles/selina-mcgee-od-faao/jl059b/Selina McGee, MD is the visionary founder and owner of BeSpoke Vision, a private practice that offers patients a wide range of optometric care via its dry eye center, specialty contact lens clinic, and aesthetics suite. She is a renowned national and international speaker and an adjunct assistant p…
- Previous
- Next